1 min read
Add as a preferred source on Google

Adagio Medical Reports $17.8 Million Q3 Net Income and $5.13 Diluted EPS Loss

Basic EPS was $2.40, and cash and cash equivalents totaled $3.1 million on Sept. 30, 2026.

A clear reserve box rests beside an uneven precision balance. / TokenPost.ai
A clear reserve box rests beside an uneven precision balance. / TokenPost.ai

Adagio Medical Holdings, Inc. (ADGM) reported $17.8 million in net income for the third quarter of 2026, alongside diluted net loss per share of $5.13. Basic earnings per share was $2.40.

The $5.13 diluted figure primarily reflected the exclusion of a noncash fair-value gain. The company had $3.1 million in cash and cash equivalents as of Sept. 30, 2026.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…